GSK PLC-SPON ADR (GSK)
US37733W2044 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 5.31B | 4.92B | 5.10B | 6.39B | 5.27B | |||
| Depreciation Amortization | 2.29B | 2.15B | 2.38B | 2.35B | 2.33B | |||
| Change In Working Capital | -2.83B | -2.10B | -773.00M | 34.00M | -1.94B | |||
| Interest Paid | 766.00M | 848.00M | 786.00M | 864.00M | 895.00M | |||
| Taxes Paid | 1.33B | 1.31B | 1.29B | 1.66B | 1.51B | |||
| Other non cash items | 1.99B | 2.43B | 1.25B | -332.00M | 2.35B | |||
| OPERATING CASH FLOW | 6.77B | 7.40B | 7.95B | 8.44B | 8.02B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.34B | -2.26B | -2.93B | -2.24B | -2.16B | |||
| Other Investing Activity | 749.00M | -6.51B | 1.15B | 4.40B | -3.19B | |||
| INVESTING CASH FLOW | -1.59B | -8.77B | -1.78B | 2.16B | -5.35B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.57B | -4.82B | -2.21B | -4.23B | 3.52B | |||
| Stock Issued/Repurchased | 10.00M | 25.00M | 21.00M | 29.00M | 51.00M | |||
| Dividend Paid | -2.25B | -3.47B | -4.00B | -3.98B | -3.95B | |||
| Other Financing Activity | -837.00M | 9.09B | -1.40B | -1.95B | -1.45B | |||
| FINANCING CASH FLOW | -5.64B | 823.00M | -7.59B | -10.13B | -1.84B | |||
| Exchange Rate Effect | -99.00M | 152.00M | -29.00M | -39.00M | -82.00M | |||
| CHANGE IN CASH | -567.00M | -394.00M | -1.44B | 431.00M | 744.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6.77B | 7.40B | 7.95B | 8.44B | 8.02B | |||
| Capital Expenditure | -2.34B | -2.26B | -2.93B | -2.24B | -2.16B | |||
| FREE CASH FLOW | 4.42B | 5.14B | 5.02B | 6.20B | 5.86B | |||
All data in GBP